In the context of infectious diseases like COVID-19, vitamin K inhibits pro-inflammatory cytokines (IL-6, IL-1β, and TNF-α) and enhances the integrity of alveolar-capillary membranes reducing the risk of acute respiratory distress syndrome (ARDS) (37). This evidence concerns the gene IL6 and acute respiratory distress syndrome.